Exposure to antibiotics during immune checkpoint inhibitor therapy may increase the risk for immune-related cutaneous adverse ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

The University of Arizona is encouraging students to fight skin cancer, a disease that hits Arizona residents 40 percent ...

For the first time, scientists have demonstrated how tanning beds cause fundamental DNA damage across almost the skin's ...

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

Immunopeptidomics is an emerging and rapidly evolving field that focuses on the identification of peptides presented by major ...

Awareness drive urges early pancreatic cancer detection PANCREATIC Cancer Awareness Month, which ran throughout November, closed on November 30 with renewed calls for early detection, stronger public ...

T-DXd plus pertuzumab improved quality-of-life outcomes, with fewer skin and mucosal symptoms but more gastrointestinal issues compared to the standard regimen. Both treatment arms showed similar pain ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

"Our veterans fought for our freedom; now they deserve hope and life-saving cancer care. No one who served should have to fight for cancer treatment or access to clinical trials," agreed Mel Mann, MBA ...

Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1Strong PFS consistent ...

Wrong site surgery is a “never event” that can be prevented by taking practical steps, according to a speaker at the American ...